Evidence map›Paper›PMID 25050323›Full record

ArticleBioMed research international2014

Sinefungin, a natural nucleoside analogue of S-adenosylmethionine, inhibits Streptococcus pneumoniae biofilm growth.

Mukesh Kumar Yadav, Seok-Won Park, Sung-Won Chae, Jae-Jun Song

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Microorganisms · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Proteomic Response ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Frontiers in microbiology · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mukesh Kumar YadavDepartment of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul 135-705, Republic of Korea.ORCID 0000-0002-4703-8554
Seok-Won ParkDepartment of Otorhinolaryngology-Head and Neck Surgery, Dongguk University Ilsan Hospital, Gyeonggi, Goyang 410-773, Republic of Korea.
Sung-Won ChaeDepartment of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul 135-705, Republic of Korea.
Jae-Jun SongDepartment of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul 135-705, Republic of Korea.ORCID 0000-0002-8488-9091
Korea University · KRDongguk University Ilsan Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pneumococcal colonization and disease is often associated with biofilm formation, in which the bacteria exhibit elevated resistance both to antibiotics and to host defense systems, often resulting in infections that are persistent and difficult to treat. We evaluated the effect of sinefungin, a nucleoside analogue of S-adenosylmethionine, on pneumococcal in vitro biofilm formation and in vivo colonization. Sinefungin is bacteriostatic to pneumococci and significantly decreased biofilm growth and inhibited proliferation and structure of actively growing biofilms but did not alter growth or the matrix structure of established biofilms. Sinefungin significantly reduced pneumococcal colonization in rat middle ear. The quorum sensing molecule (autoinducer-2) production was significantly reduced by 92% in sinefungin treated samples. The luxS, pfs, and speE genes were downregulated in biofilms grown in the presence of sinefungin. This study shows that sinefungin inhibits pneumococcal biofilm growth in vitro and colonization in vivo, decreases AI-2 production, and downregulates luxS, pfs, and speE gene expressions. Therefore, the S-adenosylmethionine (SAM) inhibitors could be used as lead compounds for the development of novel antibiofilm agents against pneumococci.

Indexed as

AdenosineAnimalsBiofilmsColony Count, MicrobialGene Expression Regulation, BacterialHomocysteineOtitis MediaPlanktonRats, Sprague-DawleyS-AdenosylmethionineStreptococcus pneumoniaeAdenosineHomocysteineS-Adenosylmethioninesinefungin

Identifiers

PMID25050323
PMCPMC4094849
OpenAlexW2095207285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.